Quarterly report pursuant to Section 13 or 15(d)

Statements of Cash Flows

v3.21.2
Statements of Cash Flows
9 Months Ended
Mar. 31, 2021
USD ($)
Cash flows from operating activities:  
Net loss $ (1,140,815)
Adjustments to reconcile net loss to net cash used in operating activities:  
Stock-based compensation 84,509
Changes in operating assets and liabilities:  
Receivable - related party 3,500
Prepaid expenses and other current assets (591,662)
Deferred offering costs (392,730)
Accounts payable 82,027
Accrued expenses 188,560
Net cash used in operating activities (1,766,611)
Cash flows from financing activities:  
Proceeds from issuance of Series A preferred milestone warrants 2,250,000
Repayment of promissory notes, related parted (201,286)
Net cash provided by financing activities 2,048,714
Net decrease in cash, cash equivalents and restricted cash 282,103
Cash and cash equivalents, beginning of period 3,024,980
Cash and cash equivalents, end of the period 3,307,083
Supplemental cash flow information:  
Cash paid for interest 13,053
Supplemental disclosure of noncash investing and financing activities:  
Fair value of warrants issued to investors 10,458,393
Deemed dividend $ 8,208,393